Literature DB >> 12569612

Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women.

Kaire Innos1, Pamela L Horn-Ross.   

Abstract

BACKGROUND: The rapid increase in the incidence of ductal carcinoma in situ (DCIS) of the breast in the U.S. has been associated with the widespread adoption of screening mammography. Little is known regarding the incidence and treatment of DCIS in women of racial/ethnic groups other than white and black. The current investigation examined recent trends and racial/ethnic differences in the incidence and treatment of DCIS in California.
METHODS: All cases of DCIS diagnosed in women age > or = 40 years in California between 1988-1999 were included. Age-adjusted incidence rates for white, black, Hispanic, and Asian-Pacific Islander women were calculated using the 2000 U.S. female population as the standard. The estimated annual percent change (EAPC) in the rates was calculated using least squares regression.
RESULTS: The average annual age-adjusted incidence of DCIS (1988-1999) was 45.3 per 100,000 in white women, 35.0 in black women, 30.9 in Asian-Pacific Islander women, and 21.8 in Hispanic women. Although a steady increase in the incidence of DCIS was noted in all racial/ethnic groups over the study period, Asian-Pacific Islander women were found to have experienced the steepest increase (EAPC = 9.1%), particularly in the age group 50-64 years (EAPC = 12.0%). The DCIS incidence was reported to increase with age in white, black, and Hispanic women, but remained fairly constant after the age of 50 years in Asian-Pacific Islanders. The proportion of women with DCIS treated with mastectomy decreased from 53% in 1988 to 32% in 1999. Younger women and Asian-Pacific Islander women reportedly were more likely to undergo mastectomy.
CONCLUSIONS: Considerable differences by race/ethnicity and age were observed in DCIS incidence and the change in the incidence in California between 1988 and 1999. Further information is needed to determine whether these differences are because of differential utilization of screening mammography or biologic characteristics of DCIS lesions. Copyright 2003 American Cancer Society

Entities:  

Mesh:

Year:  2003        PMID: 12569612     DOI: 10.1002/cncr.11104

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Tailored lay health worker intervention improves breast cancer screening outcomes in non-adherent Korean-American women.

Authors:  Hae-Ra Han; H Lee; M T Kim; K B Kim
Journal:  Health Educ Res       Date:  2008-05-07

2.  Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast.

Authors:  Adele A Bailes; Henry M Kuerer; Sara A Lari; Lovell A Jones; Abenaa M Brewster
Journal:  Cancer       Date:  2012-06-26       Impact factor: 6.860

3.  Development and validation of the assessment of health literacy in breast and cervical cancer screening.

Authors:  Hae-Ra Han; Boyun Huh; Miyong T Kim; Jiyun Kim; Tam Nguyen
Journal:  J Health Commun       Date:  2014

4.  Familiarity, Navigation, and Comprehension: Key Dimensions of Health Literacy in Pap Test Use among Korean American Women.

Authors:  Hae-Ra Han; Kyounghae Kim; Joycelyn Cudjoe; Miyong T Kim
Journal:  J Health Commun       Date:  2019-05-02

5.  Disease-free probability after the first primary ductal carcinoma in situ of the breast: a comparison between African-American and White-American women.

Authors:  Azadeh Stark; Robert Stapp; Aditya Raghunathan; Xiaowei Yan; H Lester Kirchner; Jennifer Griggs; Lisa Newman; Dhananjay Chitale; Andrew Dick
Journal:  Breast Cancer Res Treat       Date:  2011-08-27       Impact factor: 4.872

6.  Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans.

Authors:  Reina Haque; Ninah S Achacoso; Suzanne W Fletcher; Larissa Nekhlyudov; Laura C Collins; Stuart J Schnitt; Charles P Quesenberry; Laurel A Habel
Journal:  Am J Manag Care       Date:  2010-05       Impact factor: 2.229

7.  Adjuvant hormonal therapy use among women with ductal carcinoma in situ.

Authors:  Jennifer C Livaudais; E Shelley Hwang; Leah Karliner; Anna Nápoles; Susan Stewart; Joan Bloom; Celia P Kaplan
Journal:  J Womens Health (Larchmt)       Date:  2011-09-08       Impact factor: 2.681

Review 8.  Ductal carcinoma in situ: risk factors and impact of screening.

Authors:  Beth A Virnig; Shi-Yi Wang; Tatyana Shamilyan; Robert L Kane; Todd M Tuttle
Journal:  J Natl Cancer Inst Monogr       Date:  2010

9.  Ductal carcinoma in situ in African American versus Caucasian American women: analysis of clinicopathologic features and outcome.

Authors:  Hind Nassar; Bashar Sharafaldeen; Kala Visvanathan; Daniel Visscher
Journal:  Cancer       Date:  2009-07-15       Impact factor: 6.860

10.  Comparison of breast cancer survival in two populations: Ardabil, Iran and British Columbia, Canada.

Authors:  Alireza Sadjadi; T Gregory Hislop; Chris Bajdik; Morteza Bashash; Anahita Ghorbani; Mehdi Nouraie; Masoud Babaei; Reza Malekzadeh; Parvin Yavari
Journal:  BMC Cancer       Date:  2009-10-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.